VC Funding for AI in Drug Development & Clinical Trials Hits $ 5.2B
Published: January 9, 2020
06th January 2020 – Written by Ulrik Kristensen, Ph.D – Featured on Finanzen.net – The market for AI in drug development and clinical trials is maturing and entering a new phase; total funding in the industry has reached $ 5.2B , but investments have slowed down in 2019 and only 4 new companies were formed. Any new start-ups will have to prove themselves able to compete against well-funded first-generation vendors, and existing vendors are under pressure to demonstrate results. Signify Research has analyzed the investment landscape and categorized the industry into Information Synthesis, Drug Design and Clinical Trials. To download the full investment analysis in pdf format, click here .Share on LinkedIn
AI in Drug Development & Clinical TrialsTo be published September 2020
AI in Drug Development & Clinical Trials
This is a proposal for Signify Research’s 2020 report on the global market for AI in drug development & clinical trials to be published in September 2020.
Find out more